How to Value Your Company for a Capital Raise

Every capital raise negotiation comes down to one number: your valuation. Set it too high and investors walk away. Set it too low and you give away equity you will never get back. The difference between a $10 million and a $15 million pre-money valuation on a $5 million raise is 25% versus 33% ownership — a gap that compounds through every future round until exit.

Valuation is not an exact science. It is a negotiation anchored by methodology, market comparables, and the strength of your position. The issuer who can articulate a defensible valuation — backed by real data and honest assumptions — closes capital faster and at better terms than the one who picks a number and hopes investors agree.

At Angel Investors Network, we have seen nearly 1,000 capital raises since 1997, across every stage from pre-revenue startups to established funds managing hundreds of millions. The patterns are clear: overvaluation kills more deals than undervaluation, and the capital raisers who close fastest are the ones who can explain their number with specificity and conviction.

Pre-Money vs Post-Money Valuation

These two terms define the economics of every equity investment. Getting them confused — or letting investors exploit the confusion — can cost you millions in equity value.

Pre-money valuation: The value of your company before the new investment. This is the number you negotiate.

Post-money valuation: Pre-money valuation plus the new investment amount. This determines what percentage the new investor owns.

The formula: Investor ownership = Investment / Post-money valuation = Investment / (Pre-money + Investment)

Example: You negotiate a $10 million pre-money valuation and raise $2 million. Post-money is $12 million. The investor owns $2M / $12M = 16.7% of the company.

Where capital raisers get tripped up: when an investor says "I will invest $2 million at a $10 million valuation" — is that pre-money or post-money? At $10 million pre-money, the investor gets 16.7%. At $10 million post-money, the investor gets 20%. On a company that eventually exits at $100 million, that 3.3% difference is worth $3.3 million. Always clarify whether a valuation is pre-money or post-money. Always.

For SAFE notes, the distinction matters even more. The YC post-money SAFE calculates ownership based on the post-money cap, which includes all SAFE holders and the option pool. This gives founders certainty about dilution at the time of signing but can be less favorable than a pre-money SAFE at the same cap number. See our cap table guide for conversion mechanics.

The Five Primary Valuation Methods

No single method is definitive. Sophisticated investors use multiple approaches and triangulate. You should too.

1. Comparable Company Analysis (Comps). Find 5-10 companies similar to yours in industry, stage, size, and growth rate. Analyze their valuations relative to revenue, EBITDA, or users. Apply those multiples to your metrics. This is the most commonly used and most defensible method because it is grounded in market reality.

Strengths: market-based, easy to explain, investors understand it immediately. Weaknesses: finding truly comparable private companies is difficult; public company comps require an illiquidity discount (typically 20-40%).

2. Discounted Cash Flow (DCF). Project future cash flows for 5-10 years, then discount them back to present value using a discount rate that reflects the risk of the investment. This is the textbook finance approach and is most applicable to companies with predictable revenue streams.

Strengths: theoretically rigorous, captures future value. Weaknesses: highly sensitive to assumptions — a 1% change in discount rate or growth rate can swing valuation by 30-50%. Not suitable for pre-revenue companies. Experienced investors know that DCF projections for early-stage companies are largely fiction.

3. Precedent Transactions. Analyze recent acquisitions and funding rounds of comparable companies. What did similar companies raise at? What multiples were paid in M&A transactions in your sector? This method reflects actual market pricing.

Strengths: reflects real deal activity, captures market sentiment. Weaknesses: transaction details for private deals are often unavailable or incomplete; market conditions change rapidly.

4. Asset-Based Valuation. Sum the value of all tangible and intangible assets — real estate, equipment, intellectual property, contracts, customer relationships. Most relevant for asset-heavy businesses (real estate, infrastructure, manufacturing).

Strengths: grounded in tangible value, less speculative. Weaknesses: undervalues growth companies; does not capture future earnings potential; IP and intangible asset valuation is subjective.

5. Scorecard / Berkus Method (Pre-Revenue). For companies without revenue, assign value based on qualitative factors: team strength, market size, product development stage, competitive environment, and strategic partnerships. The Berkus method assigns up to $500,000 per factor across five categories, for a maximum pre-revenue valuation of $2.5 million. See the pre-revenue section below for details.

Revenue Multiples by Industry

Revenue multiples are the most common shorthand for valuation in capital raising. Here are current benchmarks:

Industry / Sector	Revenue Multiple Range	Key Driver
SaaS (high growth, >40% YoY)	10x – 20x ARR	Net revenue retention, growth rate
SaaS (moderate growth, 20-40%)	5x – 10x ARR	Rule of 40 (growth + margin)
SaaS (low growth, 3x – 5x ARR	Profitability, churn rate
Fintech	5x – 15x revenue	Regulatory moat, transaction volume
Healthcare / Biotech	4x – 12x revenue	Pipeline, FDA status, IP
E-commerce	1x – 3x revenue	Margin, brand strength, repeat rate
Real Estate (fund)	1x – 1.5x AUM	Track record, fee structure, IRR
Real Estate (operating)	8x – 15x NOI (Cap rate inverse)	Location, occupancy, lease term
Manufacturing	1x – 3x revenue	Margin, contract backlog
Professional Services	1x – 2x revenue	Recurring revenue %, client retention
AI / Machine Learning	15x – 30x+ ARR	Proprietary data, model performance

These multiples compress significantly from public markets to private markets. A public SaaS company trading at 15x ARR might translate to 8-10x ARR for a comparable private company after applying an illiquidity discount. Always use private market comparables when available — public market multiples without appropriate discounts will lead to overvaluation.

The "Rule of 40" is increasingly used as a valuation quality indicator for SaaS companies: revenue growth rate + profit margin should exceed 40%. A company growing 50% with -10% margins (40 combined) is valued comparably to one growing 25% with 15% margins (also 40).

How to Value a Pre-Revenue Company

Pre-revenue valuation is the most subjective exercise in capital raising. Without revenue, traditional financial metrics do not apply. Investors evaluate potential based on qualitative factors.

The Berkus Method. Developed by angel investor Dave Berkus, this method assigns up to $500,000 of value for each of five risk-reducing factors:

Factor	If Exists, Add Up To	What It Assesses
Sound idea (basic value)	$500,000	Market opportunity size and problem validation< /td>
Prototype (technology risk reduction)	$500,000	Working product or demonstrable technology
Quality management team	$500,000	Relevant experience, prior exits, domain expertise
Strategic relationships	$500,000	Partnerships, distribution channels, advisors
Product rollout or sales	$500,000	Early traction, beta users, LOIs

Maximum pre-revenue valuation under Berkus: $2.5 million. Some modified versions use $750,000 per factor ($3.75 million max) for companies in hot markets or with exceptional teams. The method is simple, transparent, and widely accepted in angel investing circles.

The Scorecard Method. Compare your startup to the "average" funded startup in your region and sector. Assign weightings to key factors (team 30%, market size 25%, product 15%, competitive environment 10%, marketing/sales 10%, need for additional funding 5%, other 5%). Multiply the average pre-money valuation in your region by your aggregate score.

Cost-to-duplicate. Calculate what it would cost to recreate your company from scratch: technology development costs, IP filing costs, team recruitment costs, and time investment. This sets a floor value — the company is worth at least what has been invested in building it.

For pre-revenue companies, the team is typically 50-70% of the perceived value. A second-time founder with a prior exit will command 3-5x the valuation of a first-time founder with the same idea, product, and market. This is not fair, but it is reality.

What Investors Actually Look for in a Valuation

Investors do not evaluate your valuation in isolation. They evaluate it against their return requirements, portfolio construction math, and exit probability.

Return expectations by investor type:

• Angel investors: Target 10-30x return on winners (knowing most investments will fail)
• Seed VCs: Target 10-20x return to make fund economics work
• Series A VCs: Target 5-10x return
• Growth equity: Target 3-5x return
• Real estate investors: Target 15-25% IRR, 1.5-2.5x equity multiple

An angel investor looking at your $10 million valuation is calculating: if this exits at $100 million (a strong outcome), I get 10x. Is a 10x return with a 10-20% probability of success worth the risk? That mental math determines whether your valuation is "right" — not your spreadsheet model.

What justifies a higher valuation:

• Strong revenue growth (>100% YoY for early stage)
• Proven team with prior exits
• Large market ($1B+ TAM)
• Competitive deal dynamics (multiple interested investors)
• Proprietary technology or defensible moat
• Low churn, high retention
• Capital efficiency (doing more with less)

What compresses valuation:

• No revenue or declining revenue
• First-time founder team
• Small or competitive market
• High burn rate with no clear path to profitability
• Unfavorable macro environment (rising rates compress multiples)
• Complex or messy cap table

How to Justify Your Valuation to Investors

Never present a valuation without a methodology. "We think we are worth $15 million" invites pushback. "Our comparable analysis across 8 companies in our sector at similar stage and growth rate supports a $13-17 million range, and here is the data" commands respect.

The three-column approach:

1. Comparable analysis. Show 5-8 comparable companies, their valuations, and their metrics at the time of their comparable funding round. Explain why you selected these comps and where you fit within the range.
2. Bottom-up model. Show your financial projections, apply a reasonable multiple, and discount back to present value. Be transparent about your assumptions — investors will stress-test every one.
3. Return analysis. Show the investor what their return looks like at your valuation under conservative, base, and optimistic exit scenarios. If the math works for the investor, the valuation negotiation becomes easier.

Present a range, not a single number. A $12-16 million range signals flexibility while anchoring the conversation in your favor. Be prepared to negotiate to the midpoint — sophisticated investors will push for the bottom of any range you present.

Valuation Negotiation Dynamics

Valuation negotiation is asymmetric — the investor has done this hundreds of times, and you may have done it once. Level the playing field with these principles:

Create competitive tension. The single most effective valuation lever is having multiple interested investors. A valuation that one investor finds too high becomes reasonable when two others are competing for the allocation. Run a parallel process — talk to multiple investors simultaneously.

Anchor with data, not emotion. Every number you state should be backed by a comparable, a data point, or a methodology. "Similar companies at our stage raised at 8-10x ARR" is stronger than "we feel we are worth this."

Know your walk-away number. Before entering any negotiation, define the minimum valuation you will accept. Factor in your dilution targets: if you need to retain 60% ownership to stay motivated through the next 3-4 years of building, work backward from that number.

Non-valuation levers matter. If the investor's valuation is lower than you want, negotiate on other terms: smaller option pool refresh, founder-friendly liquidation preferences (1x non-participating), board composition, pro-rata rights, or milestone-based tranches that increase the valuation as you hit targets.

Do not overoptimize. Accepting a slightly lower valuation from a strategic investor who brings connections, expertise, and follow-on capability is often better than a higher valuation from a passive investor. The best investors add value beyond capital — and they prove it by winning competitive rounds at lower valuations.

Typical Valuations by Stage

Stage	Typical Pre-Money Valuation	Typical Raise	Dilution
Pre-seed	$1M – $5M	$250K – $1M	10 – 20%
Seed	$5M – $15M	$1M – $4M	15 – 25%
Series A	$15M – $50M	$5M – $15M	15 – 25%
Series B	$50M – $200M	$15M – $50M	10 – 20%
Series C+	$200M+	$50M+	5 – 15%
Real Estate Syndication	N/A (project-based)	$1M – $50M	Sponsor promotes 20-30%
Private Fund (GP interest)	N/A (fee-based)	$10M – $500M	GP retains 1-5% commit + carry

These ranges vary significantly by geography (Silicon Valley commands 30-50% premiums over other markets), sector (AI/ML companies currently command 2-3x premiums), and market conditions (rising interest rates compress valuations across all stages). Use these as starting points, not as absolutes. For more on how these valuations translate to your cap table, see our cap table management guide.

Common Valuation Mistakes to Avoid

1. Using public company multiples without an illiquidity discount. Private company shares cannot be easily sold. A 20-40% illiquidity discount on public company multiples is standard. Presenting a valuation based on unmodified public company comparables signals either inexperience or intentional overvaluation — both damage your credibility.

2. Valuing the dream instead of the reality. A $50 million pre-money valuation for a pre-revenue company with a first-time founder requires extraordinary justification. Your valuation must reflect where you are today, not where you might be in five years. Investors price risk — the further you are from proven execution, the lower the valuation.

3. Ignoring dilution compounding. A $20 million pre-money valuation at seed sounds great. But if you need to raise three more rounds to reach profitability, model the cumulative dilution. Founders who overvalue at seed and then need to raise a down round at Series A suffer far more dilution than those who priced reasonably from the start.

4. Setting a single number with no flexibility. Investors interpret a rigid valuation as a signal that you are difficult to work with. Present a range anchored by methodology, and be prepared to negotiate within that range based on the investor's value-add, check size, and strategic fit.

5. Not accounting for the option pool shuffle. When a VC says "$10 million pre-money with a 20% option pool," the founders' effective pre-money is $8 million. Negotiate the option pool separately from the valuation, and base it on a specific hiring plan, not an arbitrary percentage. See our cap table guide for the detailed math.

Frequently Asked Questions

How do I value my company if I have no revenue?

Use the Berkus method (up to $500,000 per factor, $2.5 million max) or the Scorecard method (comparison to average funded company in your region). Focus on team quality, product development stage, market size, and competitive positioning. For most pre-revenue startups, $1-5 million pre-money is the realistic range. Anything above that requires exceptional team credentials, proprietary technology, or demonstrated traction (LOIs, pilot customers, waitlists).

What is the right valuation for a real estate syndication?

Real estate syndications are valued differently from equity investments. The property is valued based on Net Operating Income divided by capitalization rate (NOI / Cap Rate). The sponsor's economics come from promotes (typically 20-30% of profits above a preferred return), acquisition fees (1-2%), and asset management fees (1-2% of AUM). Investors evaluate the overall deal structure rather than a company valuation. See our raise capital guide for real estate-specific guidance.

Should I use a valuation expert or set the valuation myself?

For raises under $10 million, most issuers set their own valuation using comparable analysis and present it to investors for negotiation. For raises over $10 million or for complex structures (funds, multi-asset vehicles), engaging a third-party valuation firm ($5,000-$25,000) adds credibility and may be required by institutional investors. A formal 409A valuation ($1,000-$10,000) is separate and required only if you are granting stock options.

How does market timing affect valuation?

Significantly. Rising interest rates compress valuation multiples across all stages and sectors. A SaaS company that might command 12x ARR in a low-rate environment may only achieve 6-8x in a high-rate environment. Time your raise when market conditions favor your sector — but do not wait so long that you run out of runway. A lower valuation with capital in the bank beats a higher valuation that never closes.

What happens if investors think my valuation is too high?

If multiple investors independently flag your valuation as too high, they are probably right. Listen to the market. Options: reduce the valuation, restructure the offering (convertible note or SAFE with a cap that defers the valuation discussion), or demonstrate additional traction that supports the higher number. Stubbornly defending an overvaluation while your runway shrinks is a formula for a desperate down round — or failure to raise at all.

The Bottom Line

Your company valuation for a capital raise is not a number you pick — it is a number you justify. Ground it in comparable analysis, build it from defensible assumptions, and present it with the confidence of someone who has done the homework. The right valuation is the one where both you and your investors believe the deal is fair — where you retain enough equity to stay motivated and investors see enough upside to accept the risk.

Do not overoptimize on valuation at the expense of closing your round. The best valuation is the one that gets signed, funded, and deployed into building the business.

Ready to structure your raise? The Capital Raiser's OS includes valuation frameworks, comparable analysis templates, and investor presentation tools. Or download the free Raise Capital Guide to start mapping your capital strategy today.